Meléndez-Ordoñez JA

Language: Spanish
References: 21
Page: 36-40
PDF size: 488.84 Kb.

ABSTRACT

Medication administration errors are a leading cause of preventable harm in global healthcare systems, with consequences ranging from minor effects to catastrophic events, alongside a significant economic impact. In the surgical setting, particularly in anesthesiology, precision and safety are crucial for patient well-being given the high-demand environment that requires attention to detail. Medication administration errors during the perioperative period are frequent and can have severe consequences. Factors such as drug name similarities, poor labeling, and professional fatigue contribute to these incidents. Although the prevalence rates of these errors are low, their impact highlights the urgent need for effective preventive strategies. To mitigate these risks, solutions such as "Tall Man" lettering, color-coding, and label standardization have been proposed. The implementation of these strategies, along with the continuous training of healthcare professionals, is fundamental to enhancing medication administration safety.

REFERENCES

1. Melendez-Ordoñez JAJ, Antonio CAJ, Arredondo-Metzmeyali C. Seguridad en Anestesia. En: JMC, editor. Avances en seguridad del paciente. Prado; 2025. p. 149-157.

2. Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2021;30:96-105. doi: 10.1136/bmjqs-2019-010206.

3. Keers RN, Williams SD, Cooke J, Ashcroft DM. Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug Saf. 2013;36:1045-1067. doi: 10.1007/s40264-013-0090-2.

4. Bielka K, Kuchyn I, Frank M, Sirenko I, Yurovich A, Slipukha D, et al. Critical incidents during anesthesia: prospective audit. BMC Anesthesiol. 2023;23:206. doi: 10.1186/s12871-023-02171-4.

5. Rocco C, Garrido A. Seguridad del paciente y cultura de seguridad. Rev médica Clín Las Condes. 2017;28:785-795. doi: 10.1016/j.rmclc.2017.08.006.

6. Keers RN, Plácido M, Bennett K, Clayton K, Brown P, Ashcroft DM. What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff. PLoS One. 2018;13:e0206233. doi: 10.1371/journal.pone.0206233.

7. Tully MP, Ashcroft DM, Dornan T, Lewis PJ, Taylor D, Wass V. The causes of and factors associated with prescribing errors in hospital inpatients: a systematic review. Drug Saf. 2009;32:819-836. doi: 10.2165/11316560-000000000-00000.

8. Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf. 2009;32:379-389. doi: 10.2165/00002018-200932050-00002.

9. Ye J. Patient safety of perioperative medication through the lens of digital health and artificial intelligence. JMIR Perioper Med. 2023;6:e34453. doi: 10.2196/34453 .

10. Lambert BL, Schroeder SR, Galanter WL. Does Tall Man lettering prevent drug name confusion errors? Incomplete and conflicting evidence suggest need for definitive study. BMJ Qual Saf. 2016;25:213-217. doi: 10.1136/bmjqs-2015-004929.

11. Filik R, Price J, Darker I, Gerrett D, Purdy K, Gale A. The influence of tall man lettering on drug name confusion: a laboratory-based investigation in the UK using younger and older adults and healthcare practitioners. Drug Saf. 2010;33:677-687. doi: 10.2165/11532360-000000000-00000.

12. Emmerton L, Rizk MFS, Bedford G, Lalor D. Systematic derivation of an Australian standard for Tall Man lettering to distinguish similar drug names. J Eval Clin Pract. 2015;21:85-90. doi: 10.1111/jep.12247.

13. Lizano-Díez I, Figueiredo-Escribá C, Piñero-López MÁ, Lastra CF, Mariño EL, Modamio P. Prevention strategies to identify LASA errors: building and sustaining a culture of patient safety. BMC Health Serv Res. 2020;20:63. doi: 10.1186/s12913-020-4922-3.

14. Seoane-Vazquez E, Rodriguez-Monguio R, Alqahtani S, Schiff G. Exploring the potential for using drug indications to prevent look-alike and sound-alike drug errors. Expert Opin Drug Saf. 2017;16:1103-1109. doi: 10.1080/14740338.2017.1358361.

15. Filiatrault P, Hyland S. Does colour-coded labelling reduce the risk of medication errors? Can J Hosp Pharm. 2009;62:154-156. doi: 10.4212/cjhp.v62i2.446.

16. Porat N, Bitan Y, Shefi D, Donchin Y, Rozenbaum H. Use of colour-coded labels for intravenous high-risk medications and lines to improve patient safety. Qual Saf Health Care. 2009;18:505-509. doi: 10.1136/qshc.2007.025726.

17. International Organization for Standardization. User- applied labels for syringes containing drugs used during anesthesia. Colours, design and performance. ISO 26825:2020. Disponible en: https://www.iso.org/standard/76678.html

18. Boaden DB. Syringe labelling in anaesthesia and critical care areas: review 2022. 2022. Disponible en: https://anaesthetists.org/Portals/0/PDFs/Guidelines%20PDFs/Syringe%20labelling%202022%20v1.1.pdf?ver=2022-10-26-140938-370

19. Chen W, Drzymalski D. Practice variability with syringe labelling practices among anaesthesia residents. Anaesthesiol Intensive Ther. 2021;53:386-389. doi: 10.5114/ait.2021.110424.

20. Kinsella SM, Boaden B, El-Ghazali S, Ferguson K, Kirkpatrick G, Meek T, et al. Handling injectable medications in anaesthesia: guidelines from the Association of Anaesthetists. Anaesthesia. 2023;78:1285-1294. doi: 10.1111/anae.16095.

21. Gómez-Arnau JI, Otero MJ, Bartolomé A, Errando CL, Arnal D, Moreno AM, et al. Etiquetado de los medicamentos inyectables que se administran en anestesia. Rev Esp Anestesiol Reanim. 2011;58:375-383. doi: 10.1016/s0034-9356(11)70087-1.